Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial
- FIND-CKD investigators
- University of Groningen
- Indiana University Bloomington
- The University of Chicago
- University Health Network
- National Heart Centre Singapore
- Duke-NUS Graduate Medical School
- University of New South Wales
- Royal North Shore Hospital
- Aristotle University of Thessaloniki
- Providence Inland Northwest Health
- University of Washington
- University of Würzburg
- Bayer AG
- Bayer Pharmaceuticals
Research output: Contribution to journal › Article › peer-review
76
Scopus
citations